Skip to main content
. 2018 Nov;72(5):335–340. doi: 10.5455/medarh.2018.72.335-340

Table 2. Median values of uPA-PAI-1 complexes in subgroups according to clinical-pathological characteristics of the subjects (N=66). IQR: interquartile range. * statistically significant difference in mean values between groups.

Variable uPA-PAI-1 complex (median (IQR))
Menopausal status
Premenopausal 1.37 (0.76)
Post-menopause 1.35 (0.93)
Tumor size
pT1 1.20 (1.08)
pT2 1.43 (0.88)
Histological grade
G0 N/A
G1 1.58 (1.12)
G2 1.40 (1.14)
G3 1.31 (0.77)
Histological type
Invasive ductal cancer 1.43 (0.86)
Invasive lobular cancer 0.72 (0.74)
Other 1.41 (1.26)
Status of axillary lymph nodes
N0 1.37 (1.03)
N1 1.13 (0.63)
N2 1.64 (1.28)
N3 1.24
Expression of estrogen receptors
Positive 1.36 (0.96)
Negative 1.34 (0.55)
Expression of progesterone receptors 1.20 (0.97)
Positive 1.43 (0.66)
Negative
HER-2 expression *
Positive 0.99 (0.64)
Negative 1.44 (1.01)
Ki67
≤20% 1.43 (1.01)
>20% 1.47
Unknown 1.32 (0.81)
Invasion of blood vessels
Absent 1.43 (1.10)
Present 1.34 (0.80)
Neural invasion
Absent 1.35 (0.91)
Present 1.39 (0.86)